Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares TIPS Bond ETF (TIP) vs GeneDx Holdings Corp (WGS) Price & Performance

iShares TIPS Bond ETFTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

iShares TIPS Bond ETF vs GeneDx Holdings Corp — how do they compare? iShares TIPS Bond ETF trades at $106.9, while GeneDx Holdings Corp trades at $81.74 (market cap $2.32B). The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals.

TIPWGS
Sector
Fixed IncomeTechnology
52-Week High
$112.20$167.51
52-Week Low
$106.86$34.51
Market Cap
$2.32B
Enterprise Value
$2.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares TIPS Bond ETF

TIP trades at $107.08 with minimal daily movement (+0.2%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators are neutral. The stock faces headwinds from broader market concerns about inflation and Federal Reserve policy. Recent dividend distributions provide some shareholder return, but key financial ratios remain undisclosed, limiting fundamental visibility.

Outlook remains cautious due to bearish technicals and macroeconomic uncertainty. Investment opportunity hinges on inflation trends and Fed policy clarity, while risks include prolonged bond market volatility and energy price impacts. Wall Street sentiment appears mixed with technical weakness offset by dividend stability.

GeneDx Holdings Corp

GeneDx Holdings Corp. (WGS) trades at $77.08, up 10.76% today, showing strong momentum despite negative profitability metrics. The stock exhibits bullish technical signals with support at $72 and resistance at $80. Recent Q2 2026 earnings beat expectations with $0.01 EPS versus -$0.19 estimate, while revenue reached $114.4 million. However, the company faces significant challenges with a -23.4% net income margin and ongoing securities class action litigation.

Investment outlook remains cautiously optimistic given strong analyst support (90.9% buy rating) and $79.25 consensus price target. Key opportunities include growing genomic testing volumes and improved operational efficiency, while risks center on profitability challenges, legal liabilities, and high valuation multiples that may not justify current fundamentals.

Returns comparison

Trailing returns across standard periods

About iShares TIPS Bond ETF

TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.

Read more on TIP

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS